neuronext.org neuronext.org

neuronext.org

What's new in NeuroNEXT? | NeuroNEXT.org

Skip to main content. For Patients and Families. How do I access the form required to submit a proposal to NeuroNEXT? Process for Solicitation and Review of Clinical Studies for NeuroNEXT. The NeuroNEXT network pre-award process. Guidelines for Rigorous Study Design. Checklist for Evaluating Whether a Clinical Trial or Study is an Applicable Clinical Trial (ACT) for Registration on ClinicalTrials.gov. What's new in NeuroNEXT? NeuroNEXT U01 funding announcement. NeuroNEXT U24 Funding Announcement. Support...

http://www.neuronext.org/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR NEURONEXT.ORG

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

May

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Tuesday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.2 out of 5 with 12 reviews
5 star
5
4 star
6
3 star
0
2 star
0
1 star
1

Hey there! Start your review of neuronext.org

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.6 seconds

FAVICON PREVIEW

  • neuronext.org

    16x16

  • neuronext.org

    32x32

  • neuronext.org

    64x64

  • neuronext.org

    128x128

  • neuronext.org

    160x160

  • neuronext.org

    192x192

  • neuronext.org

    256x256

CONTACTS AT NEURONEXT.ORG

The University of Iowa

Richard Peters

2400 Unive●●●●●●●●●●tol Centre

Iow●●●ity , Iowa, 52242

US

1.31●●●●6872
1.31●●●●6535
ri●●●●●●●●●●●●@uiowa.edu

View this contact

The University of Iowa

Richard Peters

2400 Unive●●●●●●●●●●tol Centre

Iow●●●ity , Iowa, 52242

US

1.31●●●●6872
1.31●●●●6535
ri●●●●●●●●●●●●@uiowa.edu

View this contact

The University of Iowa

Richard Peters

2400 Unive●●●●●●●●●●tol Centre

Iow●●●ity , Iowa, 52242

US

1.31●●●●6872
1.31●●●●6535
ri●●●●●●●●●●●●@uiowa.edu

View this contact

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED
n/a
UPDATED
2012 August 27
EXPIRATION
EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

Network Solutions®

NAME SERVERS

1
ns49.domaincontrol.com
2
ns50.domaincontrol.com

REGISTRAR

GoDaddy.com, LLC (R91-LROR)

GoDaddy.com, LLC (R91-LROR)

WHOIS : whois.publicinterestregistry.net

REFERRED :

CONTENT

SCORE

6.2

PAGE TITLE
What's new in NeuroNEXT? | NeuroNEXT.org | neuronext.org Reviews
<META>
DESCRIPTION
Skip to main content. For Patients and Families. How do I access the form required to submit a proposal to NeuroNEXT? Process for Solicitation and Review of Clinical Studies for NeuroNEXT. The NeuroNEXT network pre-award process. Guidelines for Rigorous Study Design. Checklist for Evaluating Whether a Clinical Trial or Study is an Applicable Clinical Trial (ACT) for Registration on ClinicalTrials.gov. What's new in NeuroNEXT? NeuroNEXT U01 funding announcement. NeuroNEXT U24 Funding Announcement. Support...
<META>
KEYWORDS
1 projects
2 about us
3 for researchers
4 for industry
5 related links
6 get involved
7 faq's
8 media
9 publications
10 general announcements
CONTENT
Page content here
KEYWORDS ON
PAGE
projects,about us,for researchers,for industry,related links,get involved,faq's,media,publications,general announcements,study announcements,drupal login
SERVER
Apache/2.2.15 (Red Hat)
POWERED BY
PHP/5.3.3
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

What's new in NeuroNEXT? | NeuroNEXT.org | neuronext.org Reviews

https://neuronext.org

Skip to main content. For Patients and Families. How do I access the form required to submit a proposal to NeuroNEXT? Process for Solicitation and Review of Clinical Studies for NeuroNEXT. The NeuroNEXT network pre-award process. Guidelines for Rigorous Study Design. Checklist for Evaluating Whether a Clinical Trial or Study is an Applicable Clinical Trial (ACT) for Registration on ClinicalTrials.gov. What's new in NeuroNEXT? NeuroNEXT U01 funding announcement. NeuroNEXT U24 Funding Announcement. Support...

INTERNAL PAGES

neuronext.org neuronext.org
1

NN102 SPRINT MS study has reached enrollment goals | NeuroNEXT.org

https://www.neuronext.org/node/270

Skip to main content. For Patients and Families. NN102 SPRINT MS study has reached enrollment goals. The NeuroNEXT SPRINT MS study, the second research study to be conducted through the NeuroNEXT network, has attained recruitment goals. Enrollment ended on April 30, 2015. Study visits remain in progress, and will reach a conclusion late fall 2017. Please follow this link. To a press release from Medicinova, the company providing the study drug, regarding the end of enrollment.

2

For Patients & Families | NeuroNEXT.org

https://www.neuronext.org/patients-families

Skip to main content. For Patients and Families. How do I access the form required to submit a proposal to NeuroNEXT? Process for Solicitation and Review of Clinical Studies for NeuroNEXT. Guidelines for Rigorous Study Design. For Patients and Families. As study projects gain approval to begin recruitment, and activity, the NeuroNEXT group will post information with details concerning eligibility, along with contact information for those wishing to consider participation as a volunteer.

3

General Announcements | NeuroNEXT.org

https://www.neuronext.org/announcements

Skip to main content. For Patients and Families. NeuroNEXT contributes to article in Neurology Now. NeuroNEXT UO1 Funding Announcement. NeuroNEXT Pipeline Development Committee has developed a flyer to present to industry partners describing the benefits of partnering with NeuroNEXT. The National Institute of Neurological Disorders and Stroke Clinical Trials Methodology Course Now Accepting Applications for the 2016 Cohort. Neurology Today mentions NeuroNEXT in article on Clinical Trial Strategies.

4

FAQ | NeuroNEXT.org

https://www.neuronext.org/faq

Skip to main content. For Patients and Families. How do I access the form required to submit a proposal to NeuroNEXT? Process for Solicitation and Review of Clinical Studies for NeuroNEXT. Guidelines for Rigorous Study Design. How do I access the form required to submit a proposal to NeuroNEXT? Process for Solicitation and Review of Clinical Studies for NeuroNEXT. Can ancillary studies be conducted in the network?

5

NeuroNEXT’s Multicenter Trial of Rituximab in Myasthenia Gravis Announces Addition of Clinical Study Sites | NeuroNEXT.org

https://www.neuronext.org/neuronext’s-multicenter-trial-rituximab-myasthenia-gravis-announces-addition-clinical-study-sites

Skip to main content. For Patients and Families. NeuroNEXT’s Multicenter Trial of Rituximab in Myasthenia Gravis Announces Addition of Clinical Study Sites. Tuesday, March 3, 2015. The NN103 Study Team is pleased to announce the addition of 11 NeuroNEXT Clinical Study Sites (CSS) across the US. One CSS has already been activated for enrollment, and 10 more are in the process of being activated. This will bring the total number of enrolling clinical study sites to 26. This trial is coordinated by.

UPGRADE TO PREMIUM TO VIEW 13 MORE

TOTAL PAGES IN THIS WEBSITE

18

LINKS TO THIS WEBSITE

abmigroup.com abmigroup.com

| ABMI Group |

http://www.abmigroup.com/ourwork.html

The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, was created to conduct studies of treatments for neurological diseases through partnerships with academia, private foundations, and industry. ABMIG provides a biomedical informatics service to NEURONext including consulting on data integration and data sharing activities for the network, as well as, development of a cross-platform mobile application for patients to use in clinical trials for reminders to take their medications.

ctsdmc.org ctsdmc.org

Clinical Trials Statistical and Data Management Center - The University of Iowa College of Public Health

http://www.ctsdmc.org/about/aboutIndex.html

The principal mission of the CTSDMC is to provide comprehensive, premier-quality data management, statistical analysis, and administrative support services to our clients through our commitment to accuracy, efficiency, and excellence in research. The CTSDMC serves a broader mission to the academic and scientific communities by contributing new scientific knowledge and providing academic training in the development of state-of-the-art statistical methods. December 6, 2014. October 28, 2014. July 26, 2014.

espanol.ninds.nih.gov espanol.ninds.nih.gov

Enfermedad de Parkinson: Esperanza en la investigación : National Institute of Neurological Disorders and Stroke (NINDS)

https://espanol.ninds.nih.gov/trastornos/parkinson_disease_spanish.htm

National Institute of Neurological Disorders and Stroke. Prepare la página Web para imprimir. Declaración de privacidad. EL NINDS es parte de los Institutos Nacionales de la Salud. Enfermedad de Parkinson: Esperanza en la investigación. 191;Qué es la enfermedad de Parkinson? 191;Qué causa la enfermedad? 191;Qué genes están ligados a la enfermedad de Parkinson? 191;A quién le da la enfermedad de Parkinson? 191;Cuáles son los síntomas de la enfermedad? 191;Cuál es el pronóstico? Los términos en cursiva.

rutkovelab.org rutkovelab.org

Seward Rutkove Laboratory

http://www.rutkovelab.org/spinalmuscularatrophy.html

Speech and swallowing problems in neuromuscular disease. Other adult neuromuscular disorders. Injury, Disuse, and Sarcopenia. Useful references and other materials. Girl with SMA undergoing EIM on the left forearm, from our previous study completed in 2011. In which we were able to demonstrate important relationships between EIM data and functional measures, as well as differences between patients with SMA and healthy children over time. Supported by the NeuroNEXT.

neuromuscularlab.org neuromuscularlab.org

Seward Rutkove Laboratory

http://www.neuromuscularlab.org/spinalmuscularatrophy.html

Speech and swallowing problems in neuromuscular disease. Other adult neuromuscular disorders. Injury, Disuse, and Sarcopenia. Useful references and other materials. Girl with SMA undergoing EIM on the left forearm, from our previous study completed in 2011. In which we were able to demonstrate important relationships between EIM data and functional measures, as well as differences between patients with SMA and healthy children over time. Supported by the NeuroNEXT.

mg-research.org mg-research.org

Myasthenia Gravis Research Group

http://www.mg-research.org/links/index.html

MDA is a non-propfit health agency dedicated finding a cure for neuromuscular diseases. The Association supports research initiatives and sponsors hospital-affiliated clinics throughout the country, in addition to an array of other support programs and services. The MDA website can also be searched by zip code to locate the nearest office and clinic. Myasthenia Gravis Foundation of America. Myasthenia Gravis Patient Registry. My MG" mobile application. NINDS is a branch of the NIH, the national medical r...

clinicalmaterial.com clinicalmaterial.com

Useful Links - Clinical Materials Services Unit, University of Rochester

http://www.clinicalmaterial.com/UsefulLinks.aspx

National Institute for Pharmaceutical Technology and Education (NIPTE). Within the University of Rochester. Clinical Trials Coordination Center. University of Rochester Office of Human Subject Protection. URMC Central Laboratory Services. Clinical Translational Science Institute. Australia / Therapeutics Goods Administration. Canada / Therapeutic Products Directorate. European Union / European Medicines Agency. European Union / The Heads of Agencies. USA/ FDA Office of Generic Drugs.

UPGRADE TO PREMIUM TO VIEW 1 MORE

TOTAL LINKS TO THIS WEBSITE

8

OTHER SITES

neuronex.fr neuronex.fr

Neuronex Conseil - Qualité Sécurité Environnement Développement Durable

neuronexchange.com neuronexchange.com

Apache2 Ubuntu Default Page: It works

Apache2 Ubuntu Default Page. This is the default welcome page used to test the correct operation of the Apache2 server after installation on Ubuntu systems. It is based on the equivalent page on Debian, from which the Ubuntu Apache packaging is derived. If you can read this page, it means that the Apache HTTP server installed at this site is working properly. You should replace this file. Before continuing to operate your HTTP server. Package was installed on this server. Is always included from the main...

neuronexion.fr neuronexion.fr

Neuronexion | Label Indépendant, Tour, Management

LE 5 nov 2012 0 avis. Tumulte de Blanc Dis. C’est aujourd’hui la sortie officielle de Tumulte de Blanc. Enregistré au Studio Supadope en Mars dernier, découvrez dès à présent 7. LE 2 mai 2012 0 avis. Ana – Biograph. Laquo; Deux artistes talentueux qui unissent compétences techniques et sensiblité naturelle pour donner naissance à un premier opus pop folk. LE 30 avr 2012 0 avis. Ubikar – Biogr. LE 6 avr 2012 0 avis. Tumulte de Blanc Disponible! Souscription en ligne d’Ubikar . La Fin de Steno.P.

neuronexperts.com neuronexperts.com

Neuron Experts - homepage : NEURON EXPERTS

Neuron Experts - homepage. Retour à la page d'accueil. Stroke, Senile dementia. Amyotrophic lateral sclerosis (ALS) disease. Neuropathies & demyelinating diseases. Cellular models at the forefront of research to target neurodegenerative diseases. Innovative cell-based assays to support cosmetic claims. Isolated cell culture, co-cultures, organotypic cultures and HiPS. Advisory, research and development and customized solutions. Automatic segmentation algorithms and visualization functions.

neuronexpress.com neuronexpress.com

Neuron Express & Deliveries Ltd - Welcome

Error Page cannot be displayed. Please contact your service provider for more details. (6).

neuronext.org neuronext.org

What's new in NeuroNEXT? | NeuroNEXT.org

Skip to main content. For Patients and Families. How do I access the form required to submit a proposal to NeuroNEXT? Process for Solicitation and Review of Clinical Studies for NeuroNEXT. The NeuroNEXT network pre-award process. Guidelines for Rigorous Study Design. Checklist for Evaluating Whether a Clinical Trial or Study is an Applicable Clinical Trial (ACT) for Registration on ClinicalTrials.gov. What's new in NeuroNEXT? NeuroNEXT U01 funding announcement. NeuroNEXT U24 Funding Announcement. Support...

neuronexus.com neuronexus.com

Multichannel microelectrode arrays for electrophysiology - NeuroNexus

Join Our Mailing List. Design Tools and Libraries, Computational Modeling. Drs Hong Lei and Cécile Faucher. Dr Hubert Lim and Mrs. Malgorzata Straka. Dr Liset Menendez de la Prida. Dr Daniel Moran and Mr. Matthew MacEwan. In your own lab. Click to learn more. A true 3D probe for large. And small animal models. Vector Array Deep Brain Probe. Learn how to effectively use the Vector Array on our YouTube channel. DDrive Features and Implantation Strategy. Go to Mapping and Wiring. Go to Science Update.

neuronexus.wordpress.com neuronexus.wordpress.com

Neuronexus Blog | The latest technology in Neuroscience

The latest technology in Neuroscience. Come Meet Us in Italy. July 1, 2011. Comments Off on Come Meet Us in Italy. International Brain Research Organization World Congress. If you are celebrating IBRO. We hope to see you there! Comments Off on Come Meet Us in Italy. November 12, 2010. We would like to invite you to visit our booth (#2900). At the upcoming 2010 Society for Neuroscience. End of Year Inventory Sale. Visit our booth to pick up a PRINTED copy of our new 2011 Catalog which includes updated inf...

neuronexusiom.com neuronexusiom.com

Neuronexus Intraoperative Neurophysiological Monitoring Atlanta IOM

neuronexusstaging.info neuronexusstaging.info

Home - NeuroNexus

Join Our Mailing List. Design Tools and Libraries, Computational Modeling. Drs Hong Lei and Cécile Faucher. Dr Hubert Lim and Mrs. Malgorzata Straka. Dr Liset Menendez de la Prida. Dr Daniel Moran and Mr. Matthew MacEwan. 80 mm large animal. Record 256 channels,. Using precise and reliable. Chronic and acute 4 channel probes. NeuroNexus quality and reliability, starting at just $99. Go to Science Update. Learn about what other researchers are doing with NeuroNexus probes. What is Custom Design?

neuronfarm.com neuronfarm.com

Dotster

Error Page cannot be displayed. Please contact your service provider for more details. (26).